The Combination of GATA3 and CD79a as A Promising Supplemental Panel for the Diagnosis and Differentiation of Hodgkin Lymphomas. A Histological and Immunohistochemical Study - Egyptian Knowledge Bank - troweb

255879

The Combination of GATA3 and CD79a as A Promising Supplemental Panel for the Diagnosis and Differentiation of Hodgkin Lymphomas. A Histological and Immunohistochemical Study

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

DIAGNOSTIC AND PREDICTIVE VALUE OF SURVIVIN, P63 ANDCD15 IN NON HODGKIN'S LYMPHOMAS

Article

DIFFERENTIATING PARAMETERS BETWEEN HODGKIN'S DISEASE AND ANAPLASTIC LARGE CELL LYMPHOMA

Article

The significance of MUM1, BCL-6, and CD10 in identification of the cellular origin of head and neck diffuse large B-cell lymphomas. An immuno-histochemical study.

Article

Mycosis Fungoides Diagnosis Using TOX Versus Old Panel Immunohistochemical Markers

Article

Assessment of The Diagnostic Value of TOX Versus CD3 Immunohistochemical Markers in Detection of Early Mycosis Fungoides Cases

Article

EVALUATION OF NUCLEOLAR ORGANIZER REGIONS IN NON - HODGKIN'S LYMPHOMA

Article

Kappa and Lambda Determination by Single Colored Immunohistochemistry and Chromogenic in Situ Hybridization Techniques in B–Cell Malignancies

Article

Expression of Lymphocyte Homing Associated Cell Adhesion Molecule [H-CAM, CD44] in B-Lineage Neoplasms

Article

CD49 Expression in Chronic Lymphocytic Leukemia B-Cell and Non-Hodgkin Lymphoma

Article

IMMUNOHISTOCHEMISTRY IN THE DIFFE‌RENTIAL DIAGNOSIS OF SOLITARY THYROID NODULE.